dupixent
sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - přípravky proti dermatitidě, kromě kortikosteroidů - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.
afexil 500mg potahovaná tableta
zentiva, k.s., praha array - 990 monohydrÁt sodnÉ soli metamizolu - potahovaná tableta - 500mg - sodnÁ sŮl metamizolu
algadam 500mg tableta
adamed pharma s.a., czosnów array - 990 monohydrÁt sodnÉ soli metamizolu - tableta - 500mg - sodnÁ sŮl metamizolu
metamizol adamed 500mg tableta
adamed pharma s.a., czosnów array - 990 monohydrÁt sodnÉ soli metamizolu - tableta - 500mg - sodnÁ sŮl metamizolu
metamizol auxilto 500mg potahovaná tableta
auxilto healthcare s.r.o., praha array - 990 monohydrÁt sodnÉ soli metamizolu - potahovaná tableta - 500mg - sodnÁ sŮl metamizolu
metamizole kalceks 500mg/ml injekční roztok
as kalceks, riga array - 990 monohydrÁt sodnÉ soli metamizolu - injekční roztok - 500mg/ml - sodnÁ sŮl metamizolu
novalgin 500mg/ml injekční roztok
opella healthcare czech s.r.o., praha array - 990 monohydrÁt sodnÉ soli metamizolu - injekční roztok - 500mg/ml - sodnÁ sŮl metamizolu
novalgin 500mg potahovaná tableta
opella healthcare czech s.r.o., praha array - 990 monohydrÁt sodnÉ soli metamizolu - potahovaná tableta - 500mg - sodnÁ sŮl metamizolu
tritazide 5mg/25mg tableta
sanofi s.r.o., praha array - 9374 ramipril; 728 hydrochlorothiazid - tableta - 5mg/25mg - ramipril a diuretika
isicom 100mg/25mg tableta
desitin arzneimittel gmbh, hamburg array - 1645 levodopa; 12698 monohydrÁt karbidopy - tableta - 100mg/25mg - levodopa a inhibitor dekarboxylasy